← Open Payments lookup

GRACE HUGHES: Open Payments

NPI 1497128029 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,275 in 57 payments from 14 companies in 2025. Trend: 2023 $1,108 · 2024 $996 · 2025 $1,275

Food & beverage: $1,275
CompanyPaymentsAmount
GENZYME CORPORATION7$293
SANOFI-AVENTIS U.S. LLC10$226
ARS Pharmaceuticals Operations, Inc.13$186
Regeneron Healthcare Solutions, Inc.6$146
AstraZeneca Pharmaceuticals LP7$142
Novartis Pharmaceuticals Corporation3$67
Genentech USA, Inc.2$50
GlaxoSmithKline, LLC.2$30
Organon LLC2$27
Takeda Pharmaceuticals U.S.A., Inc.1$27

Products named: DUPIXENT, NEFFY, FASENRA, Rhapsido, Xolair, TEZSPIRE, TRELEGY ELLIPTA, AIRSUPRA.

Industry payments across TX — which companies pay providers there.